HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Job Harenberg Selected Research

Thrombosis (Thrombus)

11/2023COVID-19 and Long-COVID Thrombosis: From Clinical and Basic Science to Therapeutics.
1/2017New developments in anticoagulants: Past, present and future.
3/2015The impact of residual thrombosis on the long-term outcome of patients with deep venous thrombosis treated with conventional anticoagulation.
3/2015Next generation antithrombotic therapy: focus on antisense therapy against coagulation factor XI.
11/2014Glycosaminoglycans: anticoagulant and nonanticoagulant actions: a short history of symposia held at villa vigoni.
2/2011Overview on guidelines and recommendations for generic low-molecular-weight heparins.
12/2007Risk stratification and heparin prophylaxis to prevent venous thromboembolism in pregnant women.
9/2003[Treatment of thrombosis with low-molecular-weight heparin. Comparison of body weight-adjusted and fixed dosage].
9/2002Fixed-dose versus adjusted-dose low molecular weight heparin for the initial treatment of patients with deep venous thrombosis.
8/2002Comparative antithrombotic potencies of direct thrombin inhibitors and low-molecular-weight heparins in an ex vivo human experimental thrombosis model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Job Harenberg Research Topics

Disease

19Hemorrhage
04/2016 - 09/2002
18Venous Thromboembolism
12/2017 - 09/2002
13Atrial Fibrillation
01/2015 - 06/2008
10Thrombosis (Thrombus)
11/2023 - 08/2002
10Venous Thrombosis (Deep-Vein Thrombosis)
03/2015 - 08/2002
8Body Weight (Weight, Body)
05/2013 - 09/2002
7Thrombocytopenia (Thrombopenia)
01/2017 - 06/2002
7Thromboembolism
06/2016 - 09/2003
6COVID-19
11/2023 - 10/2020
6Neoplasms (Cancer)
11/2022 - 02/2010
5Infections
11/2023 - 10/2020
5Pulmonary Embolism
11/2022 - 03/2006
4Embolism (Embolus)
08/2013 - 05/2006
2Stroke (Strokes)
01/2013 - 01/2006
1Post-Acute COVID-19 Syndrome
11/2023
1Cytokine Release Syndrome
11/2023
1Anemia
11/2022
1Heart Failure
11/2022
1Hemophilia A (Haemophilia)
12/2021
1Disease Progression
01/2021
1Wounds and Injuries (Trauma)
03/2015
1Acute Disease
03/2012
1Dehydration (Water Stress)
03/2012
1Melanoma (Melanoma, Malignant)
02/2010
1Stillbirth
12/2007
1Thrombophilia
12/2007
1Osteoporosis
12/2007
1Spontaneous Abortion (Miscarriage)
12/2007
1Ischemic Stroke
01/2006
1Hypersensitivity (Allergy)
01/2005
1Atherosclerosis
08/2002
1Inflammation (Inflammations)
08/2002

Drug/Important Bio-Agent (IBA)

27AnticoagulantsIBA
11/2023 - 09/2002
17Heparin (Liquaemin)FDA LinkGeneric
10/2020 - 06/2002
11Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
01/2017 - 08/2002
8certoparin (certoparin sodium)IBA
11/2015 - 09/2002
7AntithrombinsIBA
02/2012 - 08/2002
5Warfarin (Coumadin)FDA LinkGeneric
03/2015 - 11/2002
5ThrombinFDA Link
03/2015 - 08/2002
4DabigatranFDA Link
05/2014 - 01/2012
4RivaroxabanIBA
05/2014 - 01/2012
4Enoxaparin (Lovenox)FDA LinkGeneric
11/2012 - 11/2002
3Fondaparinux (Arixtra)FDA Link
01/2017 - 08/2004
3Vitamin KFDA Link
06/2015 - 03/2015
3idraparinuxIBA
01/2010 - 06/2008
3ximelagatran (Exanta)IBA
05/2006 - 11/2002
2apixabanIBA
05/2014 - 11/2012
2N(4)-oleylcytosine arabinosideIBA
08/2013 - 11/2012
2AntibodiesIBA
02/2005 - 08/2004
2lepirudin (Refludan)FDA Link
02/2005 - 08/2004
2fibrin fragment D (D-dimer)IBA
09/2002 - 08/2002
1Toll-Like Receptors (Toll-Like Receptor)IBA
11/2023
1Angiotensin-Converting Enzyme 2IBA
11/2023
1Antiviral Agents (Antivirals)IBA
02/2023
1Fibrinolytic Agents (Antithrombotic Agents)IBA
02/2023
1cupric sulfide (CuS)IBA
11/2022
1COVID-19 VaccinesIBA
12/2021
1VaccinesIBA
01/2021
1glucuronyl glucosamine glycan sulfate (sulodexide)IBA
01/2021
1CalciumIBA
06/2016
1Antisense OligonucleotidesIBA
03/2015
1Factor XI (Plasma Thromboplastin Antecedent)IBA
03/2015
1Messenger RNA (mRNA)IBA
03/2015
1edoxabanIBA
01/2015
1GlycosaminoglycansIBA
11/2014
1prothrombin complex concentrates (PPSB)IBA
04/2014
1Cytochrome P-450 CYP2C9IBA
05/2013
1Phenprocoumon (Liquamar)FDA Link
05/2013
1Cytochrome P-450 CYP3AIBA
05/2013
1compound 18IBA
04/2012
1GlycosidesIBA
02/2010
1OligosaccharidesIBA
02/2010
1phosphomannopentaose sulfateIBA
02/2010
1idrabiotaparinuxIBA
01/2010
1Factor Xa (Coagulation Factor Xa)IBA
09/2009
1Dalteparin (Dalteparin Sodium)FDA Link
12/2007
1Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
08/2007
1argatroban (MPQA)FDA Link
02/2005
1HirudinsIBA
01/2005
1danaparoid (Orgaran)FDA Link
08/2004
1Platelet Factor 4IBA
08/2002
1Serotonin (5 Hydroxytryptamine)IBA
06/2002
1CarbonIBA
06/2002
1EnzymesIBA
06/2002

Therapy/Procedure

13Therapeutics
11/2023 - 09/2002
3Orthopedic Procedures
12/2017 - 02/2008
1Operative Surgical Procedures
11/2022
1Secondary Prevention
01/2017
1Renal Dialysis (Hemodialysis)
11/2015
1Artificial Heart (Artificial Hearts)
02/2014
1Electric Countershock (Cardioversion)
06/2008
1Stents
08/2007
1Aftercare (After-Treatment)
08/2002